DNTH vs GD · rev $6.2M vs P/E 22, rev $52.55B
Dianthus Therapeutics Inc. (DNTH) versus General Dynamics Corporation (GD) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
General Dynamics Corporation (GD) is a aerospace & defense company listed on US.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported GD revenue for 2025-12-31 was $52.55B. Net income was $4.21B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. GD currently screens at market cap $93.69B and trailing P/E 21.8.
DNTH currently screens at market cap $4.40B. GD currently screens at market cap $93.69B and trailing P/E 21.8.
Not investment advice. Open the DNTH and GD stock pages for the full models.
Not investment advice.